5-aza-2'-deoxycytidine-induced expression of functional cancer testis antigens in human renal cell carcinoma: immunotherapeutic implications.

癌症研究 癸他滨 脱甲基剂 抗原 肾细胞癌 生物 癌症 免疫疗法 低甲基化剂 医学 分子生物学 免疫学 基因表达 免疫系统 病理 DNA甲基化 内科学 基因 生物化学
作者
Sandra Coral,Luca Sigalotti,Maresa Altomonte,Arne Engelsberg,Francesca Colizzi,Ilaria Cattarossi,Eugene Maraskovsky,Elke Jäger,Barbara Seliger,Michele Maio
出处
期刊:PubMed 卷期号:8 (8): 2690-5 被引量:142
链接
标识
摘要

Limited therapeutic options are presently available for advanced renal cell carcinoma (RCC). This study was designed to define the clinical potential of the DNA hypomethylating agent 5-aza-2'-deoxycytidine (5-AZA-CdR) in human RCC, through its control of the expression of "therapeutic targets" of the cancer testis antigen (CTA) family, and of the tumor-associated antigen RAGE-1, in RCC cells.Reverse transcription (RT)-PCR assays of a panel of RCC cells treated with 5-AZA-CdR, investigated the induction of the expression of several CTAs and of RAGE-1. Immunoprecipitation and Western blotting assessed whether the expression of CTA-specific mRNA induced by 5-AZA-CdR resulted in a translated protein of appropriate molecular weight. The functional activity of de novo expressed CTA was evaluated using (51)Cr release cytotoxicity assays of 5-AZA-CdR-treated HLA-A2-positive RCC cells using HLA-A2-restricted NY-ESO-1-specific CTLs.Exposure to 5-AZA-CdR invariably induced the expression of the CTA MAGE-1, -2, -3, and -4, GAGE 1-6, and NY-ESO-1 in all of the RCC cells investigated. De novo expression of NY-ESO-1 was persistent, being still detectable 60 days after the end of treatment, and generated a functional protein efficiently recognized by HLA-A2-restricted NY-ESO-1-specific CTLs. 5-AZA-CdR also induced RAGE-1 expression in RAGE-1-negative RCC and sarcoma cells but not in neoplastic cells of different histology.This study provides the scientific rationale to establish new strategies of chemoimmunotherapy in RCC patients. The well-defined immunogenicity of the investigated CTAs and of RAGE-1 suggest that systemic administration of 5-AZA-CdR represents a promising strategy to enhance the constitutively poor immunogenic potential of RCC cells, and to propose that virtually all RCC patients receive active and/or adoptive CTA- or RAGE-1-based immunotherapy.

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
大静发布了新的文献求助10
刚刚
1秒前
1秒前
粥粥发布了新的文献求助10
2秒前
guugen完成签到,获得积分10
2秒前
2秒前
joyland发布了新的文献求助10
3秒前
lyan完成签到,获得积分10
3秒前
4秒前
善学以致用应助现代飞鸟采纳,获得10
4秒前
4秒前
称心怀蕾发布了新的文献求助10
4秒前
瘦瘦沛柔完成签到,获得积分20
4秒前
yuanbao发布了新的文献求助10
4秒前
吴123发布了新的文献求助10
4秒前
5秒前
5秒前
大米发布了新的文献求助10
5秒前
南风发布了新的文献求助100
5秒前
张先生完成签到 ,获得积分10
6秒前
爆米花应助粥粥采纳,获得10
6秒前
leyellows完成签到,获得积分10
6秒前
6秒前
6秒前
7秒前
liu发布了新的文献求助10
8秒前
Endeavor完成签到,获得积分10
8秒前
8秒前
万能图书馆应助哼哼采纳,获得10
8秒前
卜卜大王发布了新的文献求助10
9秒前
if完成签到,获得积分20
9秒前
SciGPT应助莫道雪落奈何采纳,获得10
10秒前
妮子拉完成签到,获得积分10
10秒前
niklauscheung应助chen采纳,获得10
10秒前
开放笑卉发布了新的文献求助10
11秒前
11秒前
Improve发布了新的文献求助10
11秒前
11秒前
朱大帅完成签到,获得积分10
11秒前
雍雍发布了新的文献求助10
11秒前
高分求助中
Licensing Deals in Pharmaceuticals 2019-2024 3000
Effect of reactor temperature on FCC yield 2000
Very-high-order BVD Schemes Using β-variable THINC Method 1020
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
Near Infrared Spectra of Origin-defined and Real-world Textiles (NIR-SORT): A spectroscopic and materials characterization dataset for known provenance and post-consumer fabrics 610
Mission to Mao: Us Intelligence and the Chinese Communists in World War II 600
Promoting women's entrepreneurship in developing countries: the case of the world's largest women-owned community-based enterprise 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3305566
求助须知:如何正确求助?哪些是违规求助? 2939312
关于积分的说明 8492936
捐赠科研通 2613754
什么是DOI,文献DOI怎么找? 1427569
科研通“疑难数据库(出版商)”最低求助积分说明 663115
邀请新用户注册赠送积分活动 647883